Insmed Inc (INSM)vsViridian Therapeutics Inc (VRDN)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
VRDN
Viridian Therapeutics Inc
$28.35
+4.27%
HEALTHCARE · Cap: $2.78B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 756% more annual revenue ($606.42M vs $70.85M). VRDN leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
VRDN
Avoid34
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Revenue surging 83.3% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% earnings growth
0.0% margin — thin
Weak financial health signals
ROE of -49.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : VRDN
The strongest argument for VRDN centers on Revenue Growth, Altman Z-Score. Revenue growth of 83.3% demonstrates continued momentum.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : VRDN
The primary concerns for VRDN are EPS Growth, Profit Margin, Piotroski F-Score.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while VRDN is a hypergrowth play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
VRDN is growing revenue faster at 83.3% — sustainability is the question.
VRDN generates stronger free cash flow (-24M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 34/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Viridian Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. The company is headquartered in Boulder, Colorado.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?